Trade Summary

4 days ago, Cobb Stuart, serving as Chief Scientific Officer at Neurogene Inc. (NGNE), sold 6,797 shares at $20.81 per share, for a total transaction value of $141,446.00. Following this transaction, Cobb Stuart now holds 30,497 shares of NGNE.

This sale represents a 18.00% decrease in Cobb Stuart's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, March 13, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 17, 2026, 4 days after the trade was made.